• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 08/22/14

    • 30-Day SEC Yield1

      1.75%
    • Total Net Assets

      $380.9M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2014
  • Portfolio Composition (%)
    as of 08/22/14

    • % of Net Assets
    • Stocks

      100.16
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.16
  • Download All HoldingsAll Holdings (%)as of 08/22/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    385,653
    39,760,82410.44
    Novartis Ag
    NVS US
    414,493
    36,869,1529.68
    Pfizer Inc
    PFE US
    917,065
    26,521,5206.96
    Merck & Co Inc
    MRK US
    367,036
    21,717,5205.70
    Sanofi
    SNY US
    367,404
    19,354,8435.08
    Novo Nordisk A/S
    NVO US
    408,641
    18,523,6974.86
    Actavis Plc
    ACT US
    77,075
    17,519,9184.60
    Bristol-Myers Squibb Co
    BMY US
    347,884
    17,456,8194.58
    Abbott Laboratories
    ABT US
    408,416
    17,198,3984.51
    Eli Lilly & Co
    LLY US
    274,704
    17,119,5534.49
    Teva Pharmaceutical Industries Ltd
    TEVA US
    314,287
    16,798,6404.41
    Abbvie Inc
    ABBV US
    301,247
    16,628,8344.37
    Allergan Inc/United States
    AGN US
    100,114
    16,574,8744.35
    Astrazeneca Plc
    AZN US
    220,111
    16,079,1094.22
    Glaxosmithkline Plc
    GSK US
    334,288
    15,938,8524.18
    Shire Plc
    SHPG US
    64,840
    15,855,3254.16
    Mckesson Corp
    MCK US
    66,570
    12,781,4403.36
    Valeant Pharmaceuticals International I
    VRX US
    93,292
    10,939,4202.87
    Perrigo Co
    PRGO US
    42,618
    6,359,4581.67
    Mylan Inc/Pa
    MYL US
    124,847
    6,018,8741.58
    Zoetis Inc
    ZTS US
    161,530
    5,635,7821.48
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    41,993
    2,675,7940.70
    Hospira Inc
    HSP US
    48,044
    2,623,2020.69
    Mallinckrodt Plc
    MNK US
    32,558
    2,374,7810.62
    Salix Pharmaceuticals Ltd
    SLXP US
    14,039
    2,231,6390.59
    Other/Cash
    -610,451-0.16
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.